quinazolines has been researched along with Influenza, Human in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
An, T; Han, SB; Jeong, EJ; Kim, H; Kim, M; Noh, K; Shin, JS | 1 |
Bondy, C; Chen, Y; Luo, Q; Wang, J; Zhou, X; Zhu, L | 1 |
De Pas, TM; Delmonte, A; Gregorc, V; Spitaleri, G; Toffalorio, F | 1 |
3 other study(ies) available for quinazolines and Influenza, Human
Article | Year |
---|---|
The efficacy of a 2,4-diaminoquinazoline compound as an intranasal vaccine adjuvant to protect against influenza A virus infection in vivo.
Topics: Adjuvants, Immunologic; Adjuvants, Vaccine; Administration, Intranasal; Animals; Antibodies, Viral; Humans; Immunity, Mucosal; Influenza A virus; Influenza Vaccines; Influenza, Human; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Quinazolines; Toll-Like Receptor 7 | 2022 |
AG1478 Elicits a Novel Anti-Influenza Function via an EGFR-Independent, GBF1-Dependent Pathway.
Topics: Antiviral Agents; ErbB Receptors; Guanine Nucleotide Exchange Factors; Humans; Influenza, Human; Quinazolines; Signal Transduction; Tyrphostins | 2022 |
Safety of concomitant administration of seasonal and/or H1N1 flu vaccination in patients receiving erlotinib for advanced non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines; Seasons; Vaccination | 2010 |